MAP3K13 and hepatocellular carcinoma: High expression of MAP3K13 (P = 0.049, Figure 9(e)) and MAP3K15 (P = 0.049, Figure 9(f)) was respectively demonstrated to be associated with better prognosis of HCC patients in the Guangxi cohort.